CR6773A - VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA - Google Patents
VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINAInfo
- Publication number
- CR6773A CR6773A CR6773A CR6773A CR6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A CR 6773 A CR6773 A CR 6773A
- Authority
- CR
- Costa Rica
- Prior art keywords
- myeloencephalitis
- equina
- protozoal
- vaccine against
- inactivated
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invencion proporciona un componente inmunogenicamente activo que comprende celulas de Sarcocystis neurona inactivadas y/ o celulas inactivadas de Neospora hughesi; derivados de antigenos de estas, ADN derivado de estas; o una mezcla; o en combinacion con otros componentes de vacunas contra dichos agentes infecciosos. Se proprociona ademas composiciones de vacunas utiles para prevenir o aliviar la infeccion y enfermedad de la mieloencefalitis protozoaria equina y un metodo para la propagacion de parasitos protozoarios en cultivos de celulas.The present invention provides an immunogenically active component comprising inactivated Sarcocystis neuron cells and / or inactivated Neospora hughesi cells; antigen derivatives thereof, DNA derived therefrom; or a mixture; or in combination with other components of vaccines against said infectious agents. In addition, useful vaccine compositions are provided to prevent or alleviate infection and disease of equine protozoan myeloencephalitis and a method for the propagation of protozoan parasites in cell cultures.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR6773A CR6773A (en) | 2002-10-08 | 2002-10-08 | VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR6773A CR6773A (en) | 2002-10-08 | 2002-10-08 | VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA |
Publications (1)
Publication Number | Publication Date |
---|---|
CR6773A true CR6773A (en) | 2006-05-30 |
Family
ID=44839071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR6773A CR6773A (en) | 2002-10-08 | 2002-10-08 | VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA |
Country Status (1)
Country | Link |
---|---|
CR (1) | CR6773A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10864260B2 (en) | 2015-10-28 | 2020-12-15 | Universidad Complutense De Madrid | Neospora vaccine composition |
-
2002
- 2002-10-08 CR CR6773A patent/CR6773A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10864260B2 (en) | 2015-10-28 | 2020-12-15 | Universidad Complutense De Madrid | Neospora vaccine composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marzi et al. | Vesicular stomatitis virus–based vaccines against lassa and ebola viruses | |
EA200900784A1 (en) | VACCINES INCLUDING ANTIGENS FROM FOUR STRAINS OF THE INFLUENZA VIRUS | |
Van Den Hurk et al. | Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti | |
EA200801221A1 (en) | VIRAL VACCINES OBTAINED FROM CELLS WITH LOW LEVELS OF RESIDUAL CELL DNA | |
CY1106785T1 (en) | VIRUS PARTICLES RELEASED AFTER HUMAN CYTOmegalovirus INFECTION AND THEIR USE AS A VACCINE | |
NO20023829D0 (en) | Proteosome influenza vaccine | |
ES2546403T3 (en) | Recombinant classical swine fever virus (VFPC) comprising a modified E2 protein and methods for generating said recombinant VFPC | |
ECSP045300A (en) | VIRAL ANTIGENS | |
CY1116491T1 (en) | VACCINES AGAINST FOLLOWING Fever | |
DE60142615D1 (en) | EPITOP SYNCHRONIZATION IN ANY PRESENTING CELLS | |
WO2003079757A3 (en) | Hiv therapeutic | |
BRPI0407636A (en) | cell culture medium, animal cell lineage, methods for producing a conditioned culture medium, animal cells, an animal cell culture, virus in an animal cell culture, or preferably anchor-dependent diploid human, method for produce a vaccine, and virus population | |
DE60110822D1 (en) | PREPARING FOR IMMUNIZING AGAINST THE AIDS VIRUS | |
CR8638A (en) | AGALACTIAE ESTREPTOCOCOS VACCINE | |
HRP20040195B1 (en) | West nile vaccine | |
AR036125A1 (en) | MYCOPLASMA BOVIS VACCINE METHODS TO REDUCE PNEUMONIA IN ANIMALS; VACCINE AND KIT SAID PREPARATION PROCEDURE | |
AR057225A1 (en) | VACCINES MARKED AGAINST THE VIRUS OF VIRICA BOVINA VIRUS | |
AR056712A1 (en) | COMPOSITION AND EFFECTIVE VACCINE TO TREAT TO PREVENT OR IMPROVE THE INOCULATION OF THE CANINE INFLUENZA VIRUS METHOD TO GENERATE AN IMMUNOGEN OF THE EQUINE INFLUENZA VIRUS OR OF THE VIRUS INFLUENZA MODEL OF THE USE OF THE CONTACT US TO DETERMINE THE COMPACT | |
WO2009032913A3 (en) | Thermal inactivation of rotavirus | |
WO2006029029A3 (en) | Compositions for detection of latent hiv reactivation and methods of using the same | |
ATE493495T1 (en) | GENETELY ENGINEERED CO-EXPRESSION DNA VACCINES, METHODS OF PRODUCTION THEREOF AND USES THEREOF | |
CR6773A (en) | VACCINE AGAINST MYELOENCEPHALITIS PROTOZOAL EQUINA | |
DK1578959T3 (en) | Immunization of fish against viral infection | |
Payne | Introduction to animal viruses | |
ES2100893T3 (en) | PREPARATION PROCEDURE OF A VACCINE OR TOXIC AGENT. |